Meteospasmyl

Basic information

Composition

Alverini citras 60 mg and simeticonum 300 mg in 1 capsule

Pharmacotherapeutic group

Spasmolytic agent, deflatulent (ATC code: A03AX58)

Therapeutic indications

Symptomatic treatment of functional intestinal disorders accompanied by abdominal pains or even painful spasms, compulsive diarrhoea, meteorism and flatulence. Particularly, the irritable colon is concerned. The preparation is intended only for adults.

Pharmacological properties

Meteospasmyl is a combined preparation containing alverine, a spasmolytic agent with a direct effect on the smooth muscle of the digestive tract. Alverine is more effective than papaverine and exerts fewer undesirable effects. The second component of the preparation is simethicone, which by a physical mechanism decreases the formation of gas and facilitates its removal from the digestive tract.

Pharmaceutical form

Soft capsules

More information

Posology and method of administration

Usually 1 capsule is administered 2 to 3 times a day before meals, for a period of 3 to 4 weeks. Capsules are swallowed whole, unchewed, and are washed down with a sufficient amount of liquid.

Contraindications

Hypersensitivity to any component of the preparation, ileus conditions, pregnancy and lactation, children and adolescents under 18 years of age.

Interactions

No interactions of Meteospasmyl with other drugs have been reported.

Undesirable effects

Meteospasmyl is usually very well tolerated, undesirable effects are sporadic and transitory. In the course of treatment, headache, dry mouth, nausea, weakness, vertigo, and decreased blood pressure may occur. Very rarely allergic skin rash may develop.

Special warnings and precautions for use

Caution is required when signs preceding ileus (nausea, vomiting, abdominal pains, blocking of wind and stool) occur.

Availability

The medicinal product is sold over the counter and is not covered by health insurance.

Contents of container

20 capsules of 60 mg

Package available in the Czech Republic

20 capsules of 60 mg

SPC and PIL

Detailed information

For more detailed product information, see the Summary of Product Characteristics.

Marketing authorisation holder

LABORATOIRES MAYOLY SPINDLER, 6, avenue de l’Europe – B.P. 51, 78 401 Chatou Cedex, France

Date of revision of the text

22 December 2015

Product images